Search Results 1601-1610 of 20023 for Hepatitis b

1. Phase II Trial of Irinotecan, Cetuximab, and Bevacizumab Compared With Irinotecan, Cetuximab, and Placebo in KRAS-Wildtype, Irinotecan-Refractory, Metastatic Colorectal Cancer - Mayo Clinic

   Active, uncontrolled infection, including hepatitis B, hepatitis C. Concurrent anti-cancer therapy, including chemotherapy agents, targeted agents, or ...

2. A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer - Mayo Clinic

   ... hepatitis carrier [for example, hepatitis B surface antigen (HBsAg) positive]). Screening is not required for enrollment. Have received any recent (within ...

3. Thalassemia - Diagnosis and treatment - Mayo Clinic

   It's a B vitamin that helps build red blood cells. ... You'll also need an annual flu shot, as well as vaccines to prevent meningitis, pneumonia and hepatitis B.

4. Genetic and Epigenetic Drivers of HCC in the Setting of NAFLD - Mayo Clinic Research

   Indeed, NAFLD-related HCC cases are expected to rise in the United States, and because hepatitis B and C are associated with both NAFLD and hepatocellular ...

5. Clazakizumab For The Treatment Of Chronic Active Antibody Mediated Rejection In Kidney Transplant Recipients (IMAGINE) - Mayo Clinic

   Seropositive for hepatitis B surface antigen (HBsAg). Hepatitis C virus (HCV) RNA positive. Known Epstein-Barr virus (EBV) mismatch: donor seropositive ...

6. Etanercept-ykro (subcutaneous route) - Side effects & dosage - Mayo Clinic

   Infections (eg, hepatitis B, bacteria, fungus, virus), active or history of or; Tuberculosis, active or history of—Patients with these conditions may have an ...

7. A Study to Evaluate AL102 to Treat Patients with Progressing Desmoid Tumors - Mayo Clinic

   ... hepatitis B, hepatitis C, or human immunodeficiency virus (HIV) at Screening. 4. Myocardial infarction within 6 months prior to enrollment, greater than ...

8. Neoadjuvant Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Cutaneous Stage L-lll Melanoma - Mayo Clinic

   Active or chronic infection with HIV, hepatitis B or hepatitis C; WOCBP who are unwilling or unable to use an acceptable method to avoid pregnancy for the ...

9. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis - Mayo Clinic

   Hepatitis B or Hepatitis C. - Impaired cardiac function or clinically significant cardiac diseases - Patients with Child-Pugh Class B or C - Impairment of ...

10. A Study to Assess the Effectiveness and Safety of Apremilast in Pediatric Patients (6 through 17 years old) with Moderate-to-Severe Plaque Psoriasis - Mayo Clinic

    Positive Hepatitis B surface antigen, or anti-hepatitis C antibody, at Screening. History of positive human immunodeficiency virus infection (HIV) ...